Jean I Liu Seagen Inc. (SGEN) insider trading activity

Jean I Liu is Chief Legal Officer of Seagen Inc.. Currently has a direct ownership of 0 shares of SGEN, which is worth approximately $0. The most recent transaction as insider was on Dec 14, 2023, when has been sold 48,748 shares (Common Stock) at a price of $229.0 per share, resulting in proceeds of $11,163,292. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

JEAN I LIU Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 14 2023	SELL Sale (or disposition) back to the issuer	$11,163,292 $229.0 p/Share	48,748 Reduced 100.0%	0 Common Stock
Sep 21 2023	SELL Open market or private sale	$13,216 $206.5 p/Share	64 Reduced 0.08%	84,398 Common Stock
Aug 31 2023	SELL Open market or private sale	$391,794 $206.97 p/Share	1,893 Reduced 2.19%	84,462 Common Stock
Aug 29 2023	SELL Open market or private sale	$83,430 $206.0 p/Share	405 Reduced 0.47%	86,355 Common Stock
Aug 28 2023	BUY Grant, award, or other acquisition	-	1,022 Added 1.16%	86,760 Common Stock
Aug 16 2023	SELL Sale (or disposition) back to the issuer	$583,160 $193.87 p/Share	3,008 Reduced 3.39%	85,738 Common Stock
Aug 15 2023	BUY Grant, award, or other acquisition	-	13,107 Added 12.87%	88,746 Common Stock

Aug 08 2023	SELL Bona fide gift	-	11,124 Reduced 12.82%	75,639 Common Stock
Apr 17 2023	SELL Open market or private sale	$1,029,300 $205.86 p/Share	5,000 Reduced 5.45%	86,763 Common Stock
Apr 17 2023	BUY Exercise of conversion of derivative security	$195,750 $39.15 p/Share	5,000 Added 5.17%	91,763 Common Stock
Apr 06 2023	SELL Open market or private sale	$35,819 $205.86 p/Share	174 Reduced 0.2%	86,763 Common Stock
Apr 05 2023	BUY Grant, award, or other acquisition	-	435 Added 0.5%	86,937 Common Stock
Apr 01 2023	BUY Grant, award, or other acquisition	-	1,389 Added 1.58%	86,502 Common Stock
Mar 16 2023	SELL Open market or private sale	$999,500 $199.9 p/Share	5,000 Reduced 5.55%	85,113 Common Stock
Mar 16 2023	BUY Exercise of conversion of derivative security	$195,750 $39.15 p/Share	5,000 Added 5.26%	90,113 Common Stock
Feb 16 2023	SELL Open market or private sale	$775,000 $155.0 p/Share	5,000 Reduced 5.55%	85,113 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	$195,750 $39.15 p/Share	5,000 Added 5.26%	90,113 Common Stock
Jan 24 2023	SELL Open market or private sale	$675,150 $135.03 p/Share	5,000 Reduced 5.55%	85,113 Common Stock
Jan 24 2023	BUY Exercise of conversion of derivative security	$195,750 $39.15 p/Share	5,000 Added 5.26%	90,113 Common Stock
Jan 17 2023	SELL Open market or private sale	$75,550 $130.71 p/Share	578 Reduced 0.67%	85,113 Common Stock
Jan 05 2023	SELL Open market or private sale	$610,875 $135.0 p/Share	4,525 Reduced 5.02%	85,691 Common Stock
Jan 05 2023	BUY Exercise of conversion of derivative security	$177,153 $39.15 p/Share	4,525 Added 4.78%	90,216 Common Stock
Jan 04 2023	SELL Open market or private sale	$64,125 $135.0 p/Share	475 Reduced 0.55%	85,691 Common Stock
Jan 04 2023	BUY Exercise of conversion of derivative security	$18,596 $39.15 p/Share	475 Added 0.55%	86,166 Common Stock
Nov 17 2022	SELL Open market or private sale	$1,092,039 $131.05 p/Share	8,333 Reduced 8.86%	85,691 Common Stock

Also insider at

ERAS

Erasca, Inc. Healthcare

Director

JIL

Jean I Liu

Chief Legal Officer

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Seagen Inc. insider buys or sells SGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Seagen Inc.

Track Activities on SGEN

Account